CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net Income (loss)	$ 10,434	$ (1,747)
Adjustments to reconcile net loss applicable to common shares to net cash used in operating activities:
(Gain) loss on sale of land	35	(3,716)
Gain on sale of income-producing properties.	(25,301)	(8,256)
Depreciation and amortization	10,816	11,239
Provision for impairment of notes receivable and real estate assets	800	0
Amortization of deferred borrowing costs	3,441	2,902
Earnings from unconsolidated investees.	(188)	(197)
(Increase) decrease in assets:
Accrued interest receivable	(677)	(6,471)
Other assets	0	0
Prepaid expense	(982)	(38)
Escrow	10,329	4,937
Earnest money	900	235
Rent receivables	2,991	290
Related party receivable	(871)	0
Increase (decrease) in liabilities:
Accrued interest payable	(1,472)	(6,279)
Related party payables	(10,922)	3,522
Other liabilities	(11,934)	(18,687)
Net cash used in operating activities	(12,601)	(22,266)
Cash Flow From Investing Activities:
Proceeds from notes receivables	2,855	16,055
Origination of notes receivable	(198)	(9,279)
Acquisition of land held for development	(7)	(8,503)
Proceeds from sales of income-producing properties	73,494	38,826
Proceeds from sale of land	2,550	25,248
Proceeds from sale of investment in unconsolidated real estate entities	0	0
Proceeds from sale of investments	0	132
Investment in unconsolidated real estate entities	(2,059)	3,210
Improvement of land held for development	(291)	(164)
Improvement of income-producing properties	(3,333)	(862)
Acquisition of non-controlling interest	(79)	(359)
Sale of non-controlling interest	0	(1,468)
Sale of controlling interest	52	1,149
Construction and development of new properties	(179)	(4,292)
Net cash provided by investing activities	72,805	59,693
Cash Flow From Financing Activities:
Proceeds from notes payable	137,522	138,760
Recurring amortization of principal on notes payable	(8,878)	(15,273)
Payments on maturing notes payable	(193,621)	(158,611)
Stock-secured borrowings and margin debt	(411)	0
Deferred financing costs	(1,302)	(3,127)
Distributions to non-controlling interests	(96)	(172)
Preferred stock dividends - Series A	(1,226)	(1,226)
Net cash used in financing activities	(68,012)	(39,649)
Net decrease in cash and cash equivalents	(7,808)	(2,222)
Cash and cash equivalents, beginning of period	17,141	20,312
Cash and cash equivalents, end of period	9,333	18,090
Supplemental disclosures of cash flow information:
Cash paid for interest	23,047	25,589
Schedule of noncash investing and financing activities:
Notes receivable received from related party	$ 0	$ 9,279